Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

4.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
4.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

5.8K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K
GPCR Desensitization01:12

GPCR Desensitization

6.2K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
Complement System01:27

Complement System

2.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

139
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
139

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial Infections: Host Defense and Inflammation Resolution Mechanisms for Therapy.

Current topics in microbiology and immunology·2026
Same author

Beyond host defense and tissue injury: the emerging role of neutrophils in tissue repair.

American journal of physiology. Cell physiology·2024
Same author

NRF2 Deficiency Attenuates Diabetic Kidney Disease in Db/Db Mice via Down-Regulation of Angiotensinogen, SGLT2, CD36, and FABP4 Expression and Lipid Accumulation in Renal Proximal Tubular Cells.

Antioxidants (Basel, Switzerland)·2023
Same author

Myeloperoxidase: Regulation of Neutrophil Function and Target for Therapy.

Antioxidants (Basel, Switzerland)·2022
Same author

Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

Clearing NETs with T-series resolvins.

Blood·2022

Related Experiment Video

Updated: Aug 19, 2025

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

11.9K

Targeting conformational changes in C-reactive protein to inhibit pro-inflammatory actions.

János G Filep1,2

  • 1Department of Pathology and Cell Biology, University of Montreal, Montreal, QC, Canada.

EMBO Molecular Medicine
|December 5, 2022
PubMed
Summary

Researchers developed a novel therapy targeting C-reactive protein (CRP) to reduce inflammation and tissue damage without compromising immune defense. This approach shows promise in preventing transplant rejection and kidney injury.

More Related Videos

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.6K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

580

Related Experiment Videos

Last Updated: Aug 19, 2025

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

11.9K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.6K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

580

Area of Science:

  • Biochemistry
  • Immunology
  • Translational Medicine

Background:

  • C-reactive protein (CRP) is a key marker of acute inflammation.
  • CRP exists in distinct forms with opposing functions, potentially exacerbating tissue damage.
  • Targeting harmful CRP actions is crucial for developing new therapies.

Purpose of the Study:

  • To develop a novel therapeutic agent targeting deleterious CRP functions.
  • To investigate the agent's ability to inhibit pro-inflammatory actions without affecting host defense.
  • To evaluate the therapeutic potential in models of transplant rejection and kidney injury.

Main Methods:

  • Development of a low molecular weight phosphocholine-mimetic.
  • Assessment of the agent's binding to pentameric CRP (pCRP).
  • Evaluation of the agent's effects on CRP conformation and inflammatory signaling.
  • Testing in preclinical models of allograft transplant rejection and renal ischemia-reperfusion injury.

Main Results:

  • The novel agent effectively binds to pCRP.
  • Inhibition of conformation change-mediated pro-inflammatory CRP actions was demonstrated.
  • Therapeutic benefits were observed in preventing allograft transplant rejection.
  • The agent showed efficacy in mitigating renal ischemia-reperfusion injury.

Conclusions:

  • A novel phosphocholine-mimetic effectively targets and modulates CRP activity.
  • This therapeutic strategy reduces inflammation and tissue damage while preserving host defense.
  • The findings support the development of CRP-targeted therapies for inflammatory diseases and organ injury.